Author

Andreas Schwarting

Unknown affiliation - Cited by 8,773

Biography

Dr. Andreas Schwarting belongs from the Department of Nephrology & Rheumatology, University Medical Center, Mainz at Germany. He specialises Nephrology,   Rheumatology,  Health , Innate Immunity, life biology. He has been author in more than 10 articles in different journals and other scientific magazines.   
Title
Cited by
Year
B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE)
T Möckel, F Basta, J Weinmann-Menke, A SchwartingAutoimmunity reviews 20 (2), 102736, 2021202
68
2021
Real-world effectiveness of belimumab in the treatment of systemic lupus erythematosus: pooled analysis of multi-country data from the OBSErve studies
CE Collins, J Cortes-Hernandez, MA Garcia, J von Kempis, A Schwarting, ...Rheumatology and therapy 7, 949-965, 2020202
28
2020
Patterns of fatigue and association with disease activity and clinical manifestations in systemic lupus erythematosus
L Arnaud, P Mertz, Z Amoura, RE Voll, A Schwarting, F Maurier, G Blaison, ...Rheumatology 60 (6), 2672-2677, 2021202
19
2021
The burden of systemic lupus erythematosus in Germany: incidence, prevalence, and healthcare resource utilization
A Schwarting, H Friedel, E Garal-Pantaler, M Pignot, X Wang, H Nab, ...Rheumatology and Therapy 8, 375-393, 2021202
16
2021
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.
L Cavagna, F Meloni, A Meyer, G Sambataro, M Belliato, E De Langhe, ...Clinical and Experimental Rheumatology 40 (2), 274-283, 2022202
16
2022
Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled …
JR Hoeper, J Zeidler, SE Meyer, G Gauler, P Steffens-Korbanka, ...Rmd Open 7 (1), e001627, 2021202
15
2021
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI. CAR. DA
K Triantafyllias, L Cavagna, A Klonowski, U Drott, C Fiehn, S Wendel, ...Rheumatology 60 (3), 1300-1312, 2021202
14
2021
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: A cross sectional study over 3 …
R Hasseli, U Müller-Ladner, F Keil, M Broll, A Dormann, C Fräbel, ...Rheumatology 60 (SI), SI51-SI58, 2021202
13
2021
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria
R van Vollenhoven, AD Askanase, AS Bomback, IN Bruce, A Carroll, ...Lupus Science & Medicine 9 (1), e000634, 2022202
11
2022
Identification of a rule to predict response to sarilumab in patients with rheumatoid arthritis using machine learning and clinical trial data
M Rehberg, C Giegerich, A Praestgaard, H van Hoogstraten, ...Rheumatology and Therapy 8, 1661-1675, 2021202
10
2021
Vascular inflammation and dysfunction in lupus-prone mice-IL-6 as mediator of disease initiation
P Marczynski, M Meineck, N Xia, H Li, D Kraus, W Roth, T Möckel, ...International journal of molecular sciences 22 (5), 221, 2021202
9
2021
Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
L Kaps, C Labenz, D Grimm, A Schwarting, PR Galle, O SchreinerClinical Case Reports 8 (12), 2989-2993, 2020202
7
2020
Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
S Engel, S Boedecker, P Marczynski, S Bittner, F Steffen, A Weinmann, ...Therapeutic Advances in Neurological Disorders 14, 175284211051497, 2021202
6
2021
The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosis
F Basta, T Möckel, J Petersohn, M Meineck, K Triantafyllias, S Engel, ...Autoimmunity reviews 20 (5), 102802, 2021202
4
2021
Development and validation of rheumatoid arthritis disease activity indices including HandScan (optical spectral transmission) scores
MMA Verhoeven, AAA Westgeest, A Schwarting, JWG Jacobs, C Heller, ...Arthritis care & research 7 (9), 193-199, 2022202
4
2022
Current status of use of high throughput nucleotide sequencing in rheumatology
S Boegel, JC Castle, A SchwartingRMD open 7 (1), e00134, 010
2
2021
Fatigue is independently associated with disease activity assessed using the Physician Global Assessment but not the SLEDAI in patients with systemic lupus erythematosus
P Mertz, M Piga, E Chessa, Z Amoura, RE Voll, A Schwarting, F Maurier, ...RMD open 8 (), e00395, 0
2
2022
Therapieeffekte der multimodalen rheumatologischen Komplexbehandlung im Rheumazentrum Rheinland-Pfalz
K Triantafyllias, C Sauer, A SchwartingZeitschrift für Rheumatologie 81 (7), 596-604, 0
2
2022
POS1405 OPTICAL SPECTRAL TRANSMISSION (HANDSCAN) IN PATIENTS WITH PSORIATIC ARTHRITIS: FIRST DATA ON DIAGNOSTIC VALUE AND ASSOCIATIONS WITH CLINICAL AND ULTRASOUND DISEASE …
POS405 OPTICAL SPECTRAL TRANSMISSION (HANDSCAN) IN PATIENTS WITH PSORIATIC ARTHRITIS: FIRST DATA ON DIAGNOSTIC VALUE AND ASSOCIATIONS WITH CLINICAL AND ULTRASOUND DISEASE …K Triantafyllias, S Liverakos, C Noack, A SchwartingAnnals of the Rheumatic Diseases 80 (Suppl ), 985-985, 20220
1
2021
POS1086 HIGH CARDIOVASCULAR RISK IN PATIENTS WITH PSORIATIC ARTHRITIS: EVALUATION OF MACROANGIOPATHY AND ITS PREDICTORS BY AORTIC PULSE WAVE VELOCITY.
POS086 HIGH CARDIOVASCULAR RISK IN PATIENTS WITH PSORIATIC ARTHRITIS: EVALUATION OF MACROANGIOPATHY AND ITS PREDICTORS BY AORTIC PULSE WAVE VELOCITY.K Triantafyllias, S Liverakos, A Klonowski, A SchwartingAnnals of the Rheumatic Diseases 8 (Suppl ), 869-870, 2022202
1
2022

Referred From: https://scholar.google.com/citations?user=-L8E_uEAAAAJ&hl=de

Cited by
Citations 8773
h-index 47
i10-index 112
Recommended Journals
Open Access Journals